New study aims to predict cancer recurrence in kidney and ureter cancer patients
NCT ID NCT07452432
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 300 Korean adults with high-grade upper tract urothelial carcinoma (a type of cancer in the kidney or ureter) to monitor for cancer recurrence. Participants will receive standard treatment (chemotherapy before surgery to remove the kidney and ureter) and provide blood samples to detect tumor DNA. The goal is to build a database that helps doctors better predict and track cancer return in the future.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UPPER TRACT UROTHELIAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Samsung Medical Center
RECRUITINGSeoul, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A simple blood draw could spot bladder Cancer's return
- Can a tiny ultrasound probe see how deep a urinary tract tumor goes?
- New imaging tracer could spot hidden cancers and fibrosis in one scan
- A simple urine test could revolutionize bladder cancer detection
- Two-Drug combo aims to shrink upper tract bladder cancer before surgery
- Could a drug combo spare bladder cancer patients from surgery?